INIVATA LIMITED

• ⚠

  Confirmation statement overdue

  Due 2026-08-06.

• ·

  Negative shareholders' funds

Figures converted to GBP from USD at 0.743 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. Year-on-year comparison hidden: this filing's period length differs materially from the prior year. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Company experienced a comprehensive loss of $33,329,733 (2024: $37,223,040) and has net liabilities of $118,023,908 (2024: $84,939,048), including net current liabilities of $120,877,014 (2024: $87,877,994). The Company is dependent on continued financial support from NeoGenomics which the Directors will receive for a period of at least 12 months from the date of this reporting being approved and signed as stated in the letter of support between NeoGenomics and Inivata Limited. The Directors have satisfied themselves that NeoGenomics has sufficient resources to do so and therefore consider it to be appropriate to continue preparing the financial statements on a going concern basis.”

Group structure

1. INIVATA LIMITED · parent
   1. Suzhou NeoGenomics Pharmaceutical Research Co., Limited 100%

Significant events

• “In January 2021, a competitor filed a patent infringement claim against the Company. The proceedings were subsequently stayed pending the outcome of a related matter involving the Company's Parent. The matter involving the Company's Parent was dismissed in August 2025. The matter involving the Company was dismissed in February 2026, and no related liability existed as of 31 December 2025.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.